Investigational drug · Phase 2
ALTO-207
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Treatment-resistant Depression (TRD).
Phase 2Last checked: Nov 20, 2026Latest source record: Oct 26, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
1
Any phase or sponsor naming "ALTO-207"
First trial start
2026
May 20, 2026
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "ALTO-207", any sponsor or status.
Conditions studied
As listed on its trial records.
- Treatment-resistant Depression (TRD)
Approved drugs for the same conditions: Depression (major depressive disorder) · Psychiatry
Largest trials
Live from ClinicalTrials.gov: studies naming "ALTO-207" as an intervention, largest first.
- ALTO-207 in Adults With Treatment-resistant Depression (TRD)Pivotal-lookingRecruiting
Alto NeuroscienceIndustry
NCT07553637 · 178 participants (planned) · Start May 20, 2026 · Primary completion Nov 2027
Drug: ALTO-207; Placebo · For: Treatment-resistant Depression (TRD)
Sites: Dothan, Alabama; Phoenix, Arizona; Chino, California · 63 sites in all
Newest research
PubMed records naming it or its code names, newest first.
- Next-Generation Pharmacotherapies for Unipolar Mood Disorders: A Leading Article on Phase II/III Drug Development Across Diverse Mechanisms.
King A, Hardy M, Rhee TG, et al. · CNS Drugs 2026
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.